tiprankstipranks
Blurbs

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Alnylam Pharma (ALNY), Baxter International (BAX) and Community Health (CYH)

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Alnylam Pharma (ALNYResearch Report), Baxter International (BAXResearch Report) and Community Health (CYHResearch Report).

Alnylam Pharma (ALNY)

Leerink Partners analyst Mani Foroohar maintained a Hold rating on Alnylam Pharma today and set a price target of $96.00. The company’s shares closed last Thursday at $143.16.

According to TipRanks.com, Foroohar ‘s ranking currently consits of 0 on a 0-5 ranking scale, with an average return of -23.8% and a 33.5% success rate. Foroohar covers the Healthcare sector, focusing on stocks such as Arrowhead Pharmaceuticals, 4D Molecular Therapeutics, and Recursion Pharmaceuticals.

Currently, the analyst consensus on Alnylam Pharma is a Moderate Buy with an average price target of $201.57, representing a 34.1% upside. In a report issued on April 25, Morgan Stanley also downgraded the stock to Hold with a $178.00 price target.

See today’s best-performing stocks on TipRanks >>

Baxter International (BAX)

In a report released today, Larry Biegelsen from Wells Fargo maintained a Buy rating on Baxter International, with a price target of $90.00. The company’s shares closed last Thursday at $70.80, close to its 52-week low of $69.88.

According to TipRanks.com, Biegelsen is a 5-star analyst with an average return of 16.0% and a 60.5% success rate. Biegelsen covers the Healthcare sector, focusing on stocks such as Zimmer Biomet Holdings, Tandem Diabetes Care, and Intuitive Surgical.

Baxter International has an analyst consensus of Moderate Buy, with a price target consensus of $93.00, implying a 30.7% upside from current levels. In a report issued on April 18, Leerink Partners also maintained a Buy rating on the stock with a $105.00 price target.

Community Health (CYH)

RBC Capital analyst Ben Hendrix maintained a Buy rating on Community Health today and set a price target of $19.00. The company’s shares closed last Thursday at $8.48, close to its 52-week low of $7.33.

According to TipRanks.com, Hendrix is a 1-star analyst with an average return of -2.4% and a 39.3% success rate. Hendrix covers the Healthcare sector, focusing on stocks such as Aveanna Healthcare Holdings, Brookdale Senior Living, and Bright Health Group.

Community Health has an analyst consensus of Moderate Buy, with a price target consensus of $15.20, representing a 71.8% upside. In a report released today, Citigroup also maintained a Buy rating on the stock with a $14.00 price target.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Read More on ALNY:

Tired of arriving late to the Big Returns Party?​
Most investors don’t have major gainers like TSLA or NVDA on their radar from the start.
The profusion of opinions on social media and financial blogs makes it impossible to distinguish between real growth potential and pure hype.
​​For the past decade, we have developed and perfected technology designed to help private investors, just like you, find the best opportunities, with the greatest upside potential, in any financial climate.​
Learn More
Videos
---

Latest News Feed